Inventor

KARI CSABA

US7 patents

⚠️ This page may combine multiple inventors who share the name “KARI CSABA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

HOPE CITY

3 patents

US10357571B2Jul 23, 2019

Development of masked therapeutic antibodies to limit off-target effects

HOPE CITY18 citations92

US11311622B2Apr 26, 2022

Development of masked therapeutic antibodies to limit off-target effects

HOPE CITY1 citations71

US11186642B2Nov 30, 2021

Development of masked therapeutic antibodies to limit off-target effects: application to anti-EGFR antibodies

HOPE CITY0 citations61

WILLIAMS JOHN C

1 patent

US8895702B2Nov 25, 2014

Development of masked therapeutic antibodies to limit off-target effects; application to anti-EGFR antibodies

WILLIAMS JOHN C27 citations90

WISTAR INST

1 patent

US6448389B1Sep 10, 2002

Human cytomegalovirus DNA constructs and uses therefor

WISTAR INST19 citations87

VEPEX CONTRACTOR LTD

1 patent

US5183748AFeb 2, 1993

Process for the preparation of oligo- and polydeoxyribonucleotides

VEPEX CONTRACTOR LTD5 citations52

GYOGYSZERKUTATO INTEZET

1 patent

US4294927AOct 13, 1981

Genetic process for the preparation of antibiotic-producer micromonospora strains

GYOGYSZERKUTATO INTEZET1 citations42